Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shangrao Kang Kede Biological Technology is a medical technology enterprise located in the Shangrao Economic and Technological Development Zone in Jiangxi, China. Founded in 2016, the company focuses on the research, development, and production of in vitro diagnostic (IVD) reagents and medical equipment. Its core product line includes rapid diagnostic kits for infectious diseases, such as COVID-19 antigen tests, and chronic disease management tools like blood glucose monitoring systems. The company maintains manufacturing facilities that comply with national medical device standards to serve both domestic and international markets. Kang Kede's business model encompasses the full lifecycle of medical products from initial R&D to large-scale manufacturing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 上饶市康可得生物科技.